IBM vs ZVRA · P/E 25, rev $17.16B vs P/E 6.3, rev $75.9M
International Business Machines (IBM) versus Zevra Therapeutics Inc. (ZVRA) — a side-by-side from cached financials, not a winner call.
International Business Machines (IBM) is a information technology services company listed on US. It is led by Arvind Krishna.
Zevra Therapeutics Inc. (ZVRA) is a biotechnology company listed on NASDAQ.
Latest reported IBM revenue for 2026-06-30 was $17.16B. Net income was $2.17B. Revenue was up 7.8% from 2026-03-31 to 2026-06-30. IBM currently screens at market cap $267.72B and trailing P/E 25.2.
Latest reported ZVRA revenue for 2026-06-30 was $75.9M. Net income was $46.6M. ZVRA currently screens at market cap $745.4M and trailing P/E 6.3.
IBM currently screens at market cap $267.72B and trailing P/E 25.2. ZVRA currently screens at market cap $745.4M and trailing P/E 6.3.
Not investment advice. Open the IBM and ZVRA stock pages for the full models.
Not investment advice.